Season finale to The Kardashians sees the family

Citing rise in GLP-1 popularity, longevity biote

ChromaDex partners with 1health to launch test k

BioXtek CEO Dr Bruce Werber on a new healing par

Company aims to offer at-home clinical trial ser

Pilot study explores low-dose rapamycin’s pote

Company identifies calcium signaling in the brai

Naturally occurring peptide, PEPITEM, shows prom

Shanghai-based company has multiple programs tar

Inhibiting inflammatory protein interleukin-11 l

Longevity clinic at Bumrungrad Hospital adopts p

Longeveron CEO: Lomecel-B simultaneously targets

New AFib plugin monitors smart ring wearers’ h

BioXtek is revolutionizing healthcare by turning

Company’s small molecule OGA inhibitors have s

Early-stage fund will back innovative startups i

Leveraging generative AI, Thrive AI Health seeks

Guesting on the Joint Dynamics podcast, Phil New

Company to commence clinical trials of MKK4 inhi

Predictive models offer insight into cognitive d

Vitalia CEO Niklas Anzinger on the longevity cit

Lomecel-B becomes first cell therapy to receive

Company’s ‘Immune Refresh’ approach expand

Oxford University analysis finds semaglutide doe

RF Longevity Founder Gary Arendash talks immunit

Company aims to extend female fertility window w

New insights into transcription factors and chro

If approved, HMTM would become the first oral Al

Recent study reveals significant deviations in t

Alamar Bio joins forces with Biomarkers of Aging

Significant Series B funding will enable clinica

Altos Co-founder and Chief Scientist Rick Klauns

The OSCE Parliamentary Assembly endorses longevi

Amyloid plaque-targeting therapy to be marketed

Swiss company builder demonstrates that a focus

Partnership combines advanced precision medicine

Longevity Investors Conference returns to Switze

Alden Scientific CEO on creating a GPS for longe

CIRM funding will support the company through IN

Radio frequency technology that shows promise in

TruDiagnostic launches SYMPHONYAge, the first ev

New research finds restoring telomerase activity

Company aims to ‘pave the way’ for whole-bod

C15:0 deficiency syndrome – or Cellular Fragil

Hollywood and sports stars pour $53m into health

Discover how the NUS Academy is shaping future l

Company’s RNAi drug reduces all-cause mortalit

Compare top insurance rates to get the best insura

A new therapy can reverse Alzheimer’s symptoms

Company launches suite of multi-omics tools to e